Historical record - last NADAC effective date: 1/22/2020
Product Information
BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.2168 per EA under NDC 43598053860. Its NADAC has been published 167 times since Nov 23, 2016.
FDA first approved this application on Mar 1, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598053860
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
1/22/2020
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205794FDA Approved
3/1/2016
TE Code
AB1
On Market Since
8/1/2016
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 167 times since Nov 23, 2016, and over the history we have for it it has declined 34.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2168 per EA |
|---|---|
| All-time high | $0.3306 (Dec 14, 2016) |
| All-time low | $0.2079 (Sep 18, 2019) |
| Median price | $0.2566 |
| Average price | $0.2631 |
| Largest weekly change | -15.6% (Jul 17, 2019) |
| Weeks tracked | 167 |
| Tracking since | Nov 23, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-34.4%
Last surveyed Jan 29, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.2168 per EA (NDC 43598053860), effective Jan 29, 2020.
How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 34.4%. It has been tracked across 167 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?
Since Nov 23, 2016, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.2079 (Sep 18, 2019) to a high of $0.3306 (Dec 14, 2016), with a median of $0.2566 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL SR 200 MG TABLET, is $0.1087 per EA — about 50% below BUPROPION HCL SR 200 MG TABLET.
Who manufactures BUPROPION HCL SR 200 MG TABLET?
BUPROPION HCL SR 200 MG TABLET (NDC 43598053860) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.